Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma

NCT00107003 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00107003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00107003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
March 30, 2005
Completion date
November 30, 2012
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, gbm, glioblastoma multiforme, glioma, gliosarcoma, gs